Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells.

Jewett A, Tseng HC.

Cancer Immunol Immunother. 2012 Feb;61(2):265-74. doi: 10.1007/s00262-011-1163-7. Epub 2011 Nov 25. Review.

PMID:
22116348
2.

Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells.

Jewett A, Tseng HC, Arasteh A, Saadat S, Christensen RE, Cacalano NA.

Curr Drug Deliv. 2012 Jan;9(1):5-16. Review.

PMID:
22023212
3.

Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells.

Tseng HC, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Ishikawa TO, Herschman HR, Cacalano N, Pyle AD, Park NH, Jewett A.

PLoS One. 2010 Jul 16;5(7):e11590. doi: 10.1371/journal.pone.0011590.

4.
6.

Natural killer cells as effectors of selection and differentiation of stem cells: role in resolution of inflammation.

Jewett A, Man YG, Cacalano N, Kos J, Tseng HC.

J Immunotoxicol. 2014 Oct;11(4):297-307. doi: 10.3109/1547691X.2013.877104. Epub 2014 Feb 27. Review.

PMID:
24575813
8.

Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity.

Jewett A, Arasteh A, Tseng HC, Behel A, Arasteh H, Yang W, Cacalano NA, Paranjpe A.

PLoS One. 2010 Mar 31;5(3):e9874. doi: 10.1371/journal.pone.0009874.

9.

Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.

Jewett A, Teruel A, Romero M, Head C, Cacalano N.

Cancer Immunol Immunother. 2008 Jul;57(7):1053-66. doi: 10.1007/s00262-007-0437-6.

PMID:
18188563
10.
11.
12.

Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F.

Magister Š, Tseng HC, Bui VT, Kos J, Jewett A.

Oncotarget. 2015 Sep 8;6(26):22310-27.

13.

Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation.

Jewett A, Cacalano NA, Teruel A, Romero M, Rashedi M, Wang M, Nakamura H.

Cancer Immunol Immunother. 2006 Sep;55(9):1052-63. Epub 2005 Nov 18.

PMID:
16328384
14.

Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.

Zancope E, Costa NL, Junqueira-Kipnis AP, Valadares MC, Silva TA, Leles CR, Mendonça EF, Batista AC.

J Oral Pathol Med. 2010 Feb;39(2):162-7. doi: 10.1111/j.1600-0714.2009.00792.x. Epub 2009 Sep 14.

PMID:
19754647
15.

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.

Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP Jr, Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA, Childs RW.

Blood. 2004 Jul 1;104(1):170-7. Epub 2004 Mar 11.

16.

Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.

Kozlowska AK, Tseng HC, Kaur K, Topchyan P, Inagaki A, Bui VT, Kasahara N, Cacalano N, Jewett A.

Cancer Immunol Immunother. 2016 Sep;65(9):1085-97. doi: 10.1007/s00262-016-1866-x. Epub 2016 Jul 20.

17.
18.
19.

Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors.

Tseng HC, Bui V, Man YG, Cacalano N, Jewett A.

Front Immunol. 2014 Jun 19;5:269. doi: 10.3389/fimmu.2014.00269. eCollection 2014.

20.

Supplemental Content

Support Center